BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 20232762)

  • 1. A five year review of the complications of progestogen only injectable contraceptive at the University of Port-Harcourt Teaching Hospital.
    Ojule JD; Oriji VK; Okongwu C
    Niger J Med; 2010; 19(1):87-95. PubMed ID: 20232762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with injectable progestogen- only contraceptives at University of Ilorin teaching hospital: a five year review.
    Balogun OR; Raji HO
    Niger Postgrad Med J; 2009 Dec; 16(4):260-3. PubMed ID: 20037621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progestogen-only injectable contraceptive: experience of women in Osogbo, southwestern Nigeria.
    Adeyemi AS; Adekanle DA
    Ann Afr Med; 2012; 11(1):27-31. PubMed ID: 22199044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A survey of different approaches to management of menstrual disturbances in women using injectable contraceptives.
    Fraser IS
    Contraception; 1983 Oct; 28(4):385-97. PubMed ID: 6230212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of depot medroxyprogesterone acetate (DMPA) injectable contraceptive in Enugu, Nigeria.
    Hu E; Ikeako LC; Obiora-Okafor NC
    Niger J Med; 2012; 21(3):266-71. PubMed ID: 23304918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic effects of once-a-month combined injectable contraceptives.
    Sang GW
    Contraception; 1994 Apr; 49(4):361-85. PubMed ID: 8013220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability of injectable contraceptives in Assiut, Egypt.
    Salem HT; Salah M; Aly MY; Thabet AI; Shaaban MM; Fathalla MF
    Contraception; 1988 Dec; 38(6):697-710. PubMed ID: 2975583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh.
    Swenson I; Khan AR; Jahan FA
    Contraception; 1980 Mar; 21(3):207-15. PubMed ID: 6446442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal wetness: an underestimated problem experienced by progestogen injectable contraceptive users in South Africa.
    Smit J; McFadyen L; Zuma K; Preston-Whyte E
    Soc Sci Med; 2002 Nov; 55(9):1511-22. PubMed ID: 12297238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progestogen-only injectable contraceptive: Acceptor prevalence and client experience at Sagamu, Nigeria.
    Akadri AA; Odelola OI
    Niger Postgrad Med J; 2017; 24(3):178-181. PubMed ID: 29082908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once-a-month injectable contraceptives: efficacy and reasons for discontinuation.
    Koetsawang S
    Contraception; 1994 Apr; 49(4):387-98. PubMed ID: 8013221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-acting hormonal contraceptives for women.
    Garza-Flores J; Hall PE; Perez-Palacios G
    J Steroid Biochem Mol Biol; 1991; 40(4-6):697-704. PubMed ID: 1958567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given by intramuscular injection to Chinese women. II. The comparison of bleeding patterns.
    Sang GW; Shao QX; Ge RS; Ge JL; Chen JK; Song S; Fang KJ; He ML; Luo SY; Chen SF
    Contraception; 1995 Mar; 51(3):185-92. PubMed ID: 7621686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depot medroxyprogesterone injectable contraception at the University of Uyo Teaching Hospital, Uyo.
    Abasiattai AM; Udoma EJ; Ukeme E
    Ann Afr Med; 2010; 9(2):81-5. PubMed ID: 20587929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal bleeding patterns in women using once-a-month injectable contraceptives.
    Fraser IS
    Contraception; 1994 Apr; 49(4):399-420. PubMed ID: 8013222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient acceptability and satisfaction with Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension).
    Shulman LP; Oleen-Burkey M; Willke RJ
    Contraception; 1999 Oct; 60(4):215-22. PubMed ID: 10640168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facts about once-a-month injectable contraceptives: memorandum from a WHO meeting.
    Bull World Health Organ; 1993; 71(6):677-89. PubMed ID: 8313486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal bleeding patterns of women using different contraceptive methods (implants, injectables, IUDs, oral pills)--an Indian experience. An ICMR Task Force Study. Indian Council of Medical Research.
    Datey S; Gaur LN; Saxena BN
    Contraception; 1995 Mar; 51(3):155-65. PubMed ID: 7621684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Return of fertility in women discontinuing injectable contraceptives.
    Fotherby K; Howard G
    J Obstet Gynaecol (Lahore); 1986 Apr; 6 Suppl 2():S110-5. PubMed ID: 12315276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.